Seizure drug Qudexy XR approved for use in younger patients

Qudexy XR, a treatment option for seizures, has been approved for an expanded indication that will allow it to be used In patients as young as 2 years old, drug maker Upsher-Smith said on Monday. This treatment already had been approved for patients 10 and up since June 2014. It Is primarily used as a therapeutic measure for patients prone to partial-onset or primary generalized tonic-clonic seizures. The capsules can be ground into a fine powder and sprinkled onto soft food for patients who h Read More »

PQS, Prime Therapeutics team up in drug-adherence project

Pharmacy Quality Solutions (PQS) said on Monday that it will partner with Prime Therapeutics LLC to improve medication-use regimens through collaboration with prescription-drug plans and community pharmacies. "Prime's work with PQS supports our purpose in helping people get the medicine they need to feel better and live well," Scott Fries, senior vice president of government programs at Prime, said. Read More »